Multicenter, double blind, metronidazole controlled, dose range finding study of nitazoxanide in the treatment of Clostridium difficile colitis

Trial Profile

Multicenter, double blind, metronidazole controlled, dose range finding study of nitazoxanide in the treatment of Clostridium difficile colitis

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Mar 2015

At a glance

  • Drugs Nitazoxanide (Primary) ; Metronidazole
  • Indications Clostridium infections; Colitis
  • Focus Therapeutic Use
  • Sponsors Romark Laboratories
  • Most Recent Events

    • 18 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top